These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1264 related articles for article (PubMed ID: 26747705)

  • 1. TGF-β/SMAD Pathway and Its Regulation in Hepatic Fibrosis.
    Xu F; Liu C; Zhou D; Zhang L
    J Histochem Cytochem; 2016 Mar; 64(3):157-67. PubMed ID: 26747705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liuweiwuling tablets attenuate BDL-induced hepatic fibrosis via modulation of TGF-β/Smad and NF-κB signaling pathways.
    Liu H; Dong F; Li G; Niu M; Zhang C; Han Y; He L; Yin P; Wang B; Sang X; Li R; Wang J; Bai Z; Xiao X
    J Ethnopharmacol; 2018 Jan; 210():232-241. PubMed ID: 28864168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Central role of dysregulation of TGF-β/Smad in CKD progression and potential targets of its treatment.
    Chen L; Yang T; Lu DW; Zhao H; Feng YL; Chen H; Chen DQ; Vaziri ND; Zhao YY
    Biomed Pharmacother; 2018 May; 101():670-681. PubMed ID: 29518614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isorhamnetin attenuates liver fibrosis by inhibiting TGF-β/Smad signaling and relieving oxidative stress.
    Yang JH; Kim SC; Kim KM; Jang CH; Cho SS; Kim SJ; Ku SK; Cho IJ; Ki SH
    Eur J Pharmacol; 2016 Jul; 783():92-102. PubMed ID: 27151496
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Asiatic acid inhibits liver fibrosis by blocking TGF-beta/Smad signaling in vivo and in vitro.
    Tang LX; He RH; Yang G; Tan JJ; Zhou L; Meng XM; Huang XR; Lan HY
    PLoS One; 2012; 7(2):e31350. PubMed ID: 22363627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The transforming growth factor-beta/SMAD signaling pathway is present and functional in human mesangial cells.
    Poncelet AC; de Caestecker MP; Schnaper HW
    Kidney Int; 1999 Oct; 56(4):1354-65. PubMed ID: 10504488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Puerarin, isolated from Pueraria lobata (Willd.), protects against hepatotoxicity via specific inhibition of the TGF-β1/Smad signaling pathway, thereby leading to anti-fibrotic effect.
    Xu L; Zheng N; He Q; Li R; Zhang K; Liang T
    Phytomedicine; 2013 Oct; 20(13):1172-9. PubMed ID: 23856441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The expression dynamics of transforming growth factor-β/Smad signaling in the liver fibrosis experimentally caused by Clonorchis sinensis.
    Yan C; Wang L; Li B; Zhang BB; Zhang B; Wang YH; Li XY; Chen JX; Tang RX; Zheng KY
    Parasit Vectors; 2015 Feb; 8():70. PubMed ID: 25649869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chrysophanol ameliorates renal interstitial fibrosis by inhibiting the TGF-β/Smad signaling pathway.
    Dou F; Ding Y; Wang C; Duan J; Wang W; Xu H; Zhao X; Wang J; Wen A
    Biochem Pharmacol; 2020 Oct; 180():114079. PubMed ID: 32511988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TGF-β1 mediated Smad signaling pathway and EMT in hepatic fibrosis induced by Nano NiO in vivo and in vitro.
    Zhang Q; Chang X; Wang H; Liu Y; Wang X; Wu M; Zhan H; Li S; Sun Y
    Environ Toxicol; 2020 Apr; 35(4):419-429. PubMed ID: 31737983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transforming growth factor-β/Smad signalling in diabetic nephropathy.
    Lan HY
    Clin Exp Pharmacol Physiol; 2012 Aug; 39(8):731-8. PubMed ID: 22211842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TGF-beta activated Smad signalling leads to a Smad3-mediated down-regulation of DSPP in an odontoblast cell line.
    He WX; Niu ZY; Zhao SL; Jin WL; Gao J; Smith AJ
    Arch Oral Biol; 2004 Nov; 49(11):911-8. PubMed ID: 15353247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diverse roles of TGF-β/Smads in renal fibrosis and inflammation.
    Lan HY
    Int J Biol Sci; 2011; 7(7):1056-67. PubMed ID: 21927575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transforming growth factor-beta and Smad signalling in kidney diseases.
    Wang W; Koka V; Lan HY
    Nephrology (Carlton); 2005 Feb; 10(1):48-56. PubMed ID: 15705182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of the TGF-β/BMP-7/Smad pathways in renal diseases.
    Meng XM; Chung AC; Lan HY
    Clin Sci (Lond); 2013 Feb; 124(4):243-54. PubMed ID: 23126427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New insights into TGF-β/Smad signaling in tissue fibrosis.
    Hu HH; Chen DQ; Wang YN; Feng YL; Cao G; Vaziri ND; Zhao YY
    Chem Biol Interact; 2018 Aug; 292():76-83. PubMed ID: 30017632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chrysin attenuates liver fibrosis and hepatic stellate cell activation through TGF-β/Smad signaling pathway.
    Balta C; Herman H; Boldura OM; Gasca I; Rosu M; Ardelean A; Hermenean A
    Chem Biol Interact; 2015 Oct; 240():94-101. PubMed ID: 26297989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Poricoic acid ZA, a novel RAS inhibitor, attenuates tubulo-interstitial fibrosis and podocyte injury by inhibiting TGF-β/Smad signaling pathway.
    Wang M; Chen DQ; Wang MC; Chen H; Chen L; Liu D; Zhao H; Zhao YY
    Phytomedicine; 2017 Dec; 36():243-253. PubMed ID: 29157821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Exogenous Fetuin-A on TGF-
    Zhou Y; Yang S; Zhang P
    Biomed Res Int; 2016; 2016():8462615. PubMed ID: 27990439
    [No Abstract]   [Full Text] [Related]  

  • 20. Tanshinone IIA attenuates silica-induced pulmonary fibrosis via inhibition of TGF-β1-Smad signaling pathway.
    Feng F; Li N; Cheng P; Zhang H; Wang H; Wang Y; Wang W
    Biomed Pharmacother; 2020 Jan; 121():109586. PubMed ID: 31706104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 64.